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The common presenting symptoms of pancreatic cancer are abdominal pain, weight loss, and jaundice.
Pancreatic adenocarcinoma presenting with diabetic ketoacidosis is a very rare emergent clinical con-
dition. However, pancreatic ductal cystadenocarcinoma presenting with diabetic ketoacidosis was not
reported. We describe a 60-year-old man with pancreatic cystadenocarcinoma presenting with diabetic
ketoacidosis as the initial manifestation. It must be kept in mind that in diabetic ketoacidosis cases, the
precipitating factor may be pancreatic ductal cystadenocarcinoma.
Copyright © 2016 The Emergency Medicine Association of Turkey. Production and hosting by Elsevier
B.V. on behalf of the Owner. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The relationship between pancreatic cancer and diabetes is
controversial.1 Patients with pancreatic cancer might have
abdominal pain, weight loss, jaundice, back pain, vomiting, indi-
gestion, and pruritus.2 Pancreatic adenocarcinoma presenting with
diabetic ketoacidosis (DKA) is very rare and to the best of our
knowledge, only three cases have previously been reported.3e5
However, pancreatic cystadenocarcinoma presenting with DKA is
not known. Here, we present a case of pancreatic cys-
tadenocarcinoma whose presenting symptom was DKA.2. Case presentation
A 60-year-old male patient presented to the emergency
department of our hospital with the complaints of weakness,
nausea and loss of appetite for 3 days. Therewas about 10 kgweight
loss during the last 2months. He had type 2 diabetes for 5 years and
had been taking metformin 2000 mg/day for 3 years. Patient hadof Medicine, Department of
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icine (2016), http://dx.doi.orghigh blood sugar readings at home for the last two months, but he
didn't seek medical attention for this. He smoked 5 cigarettes daily
for thirty years. On physical examination, he was conscious, arterial
blood pressure was 130/85 mmHg, pulse rate was 110/min, and the
body temperature was 36.6 C. His tongue was dry, skin turgor and
tonus were decreased. The patient's body mass index was 32.3 kg/
m2. The initial laboratory results were as follows: Serum glucose
473 mg/dL, urea 69 mg/dL, creatinine 2 mg/dL, sodium 132 mEq/L,
potassium 4.3 mEq/L, chloride 97 mEq/L, alanine aminotransferase
29 U/L, aspartate aminotransferase 34 U/L, total bilirubin 0.3mg/dL,
direct bilirubin 0.1 mg/dL, and HbA1c 12.5%. Ketones and glucose
were both 3 þ and density (speciﬁc gravity 1028) was increased on
urine analysis. Arterial blood gas analysis showed increased anion
gap metabolic acidosis (pH 7.28, PaCO2 25.7 mmHg, HCO3
14.4 mEq/L, PaO2 88.2 mmHg, SaO2 95.8%, lactate 1.5 mg/dL and
anion gap 26.5 mEq/L). He was admitted to our clinic and intra-
venous ﬂuids, electrolytes, and regular insulin infusion were star-
ted. Urea and creatinine values returned to normal range and the
clinical picture of DKA improved. Intensive SC insulin treatment
was begun. Level of CA19-9 was 202 U/ml (reference range 0e37).
On the abdominal ultrasonography, a hypoechogenic lesion was
observed in the pancreatic head, which had internal septations and
produced sonic posterior wall echoes. On the abdominal CT, a cystic
necrotic mass of 54  42 mm dimensions was observed in the head
of pancreas; it surrounded the gastroduodenal artery and invaded
the portal and splenic veins (Fig. 1). No metastasis was detected.
However, general surgery decided that the patient was inoperableand hosting by Elsevier B.V. on behalf of the Owner. This is an open access article
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Fig. 1. Abdominal contrast-enhanced CT scan showing the solid and cystic mass in the head of the pancreas. Axial (A) and coronal (B) images in the arterial phase. Axial (C) and
coronal (D) images in the portal phase. The lesion invaded the portal vein.
T. Kaya et al. / Turkish Journal of Emergency Medicine xxx (2016) 1e32due to the vascular invasion. Icterus developed progressively after
the fourth day of hospitalization. While biliary tree was seen to
be normal on the admission ultrasonography, repeat USG on
the ﬁfth day revealed that intrahepatic biliary ducts and the chol-
edocus were dilated. Obstructive icterus developed secondary to
the mass at the head of pancreas. Endoscopic retrograde chol-
angiopancreatography was performed and a stent was placed for
the malignant stenosis at the distal part of the choledocus. In theFig. 2. Histopathology showing the development of malignant tumor as pancreatic duc
embedded in desmoplastic stroma (Images A and B).
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normal. The histopathological assessment of the mass in the head
of the pancreas, from which a biopsy specimen was obtained
through percutaneous ﬁne needle aspiration, was found to be
consistent with pancreatic ductal adenocarcinoma (PDAC) (Fig. 2).
The patient's blood glucose was regulated with basal and mealtime
insulin treatment. The patient was discharged and referred to the
medical oncology outpatient clinic.tal adenocarcinoma with consisting pleomorphic cells, inﬁltrative appearance, and
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Pancreatic cancer is more frequent among individuals60 years
old, and in the United States, it is ranked in the fourth place among
deaths caused by cancer.6 Over 95% of these cancers originate from
exocrine pancreatic cells and the most frequent histological form is
PDAC (85%).2 Although PDAC is solid in general, in 8% of the cases, it
may comprise cyst-like features such as cystic degeneration,
retention cysts, and attached pseudocysts.7 PDAC with cystic fea-
tures as in the present patient is rare. The differential diagnosis of
pancreatic benign cystic lesions from PDAC is clinically important.
Lv et al reported that the following CT imaging features may be
useful for the diagnosis of PDAC: irregular contour, multiple cysts,
mural nodes, localized thickening, dilatation of the main pancreatic
duct, peripancreatic fat inﬁltration, and vascular or peripheral tis-
sue involvement.8 On the CT of the present patient, there were
irregular contour, vascular and peripheral tissue involvement,
rendering consideration of PDAC.
It has been demonstrated in previous studies that pancreatic
cancer and diabetes can both be the cause of one another, and can
affect one another as a result.1 In a meta-analysis, Ben et al had
reported that there was a two-fold risk of developing pancreatic
cancer in diabetic patients.9 There is glucose intolerance or frank
diabetes in about 80% of patients with pancreatic cancer.2 The
mechanism of development of diabetes related to pancreatic cancer
is not completely understood.10 Mechanical obstruction of the
pancreatic duct, hyperinsulinism and insulin resistance, tumor size
and genetic variants have been claimed to possibly be effective.1,10
All of the afore-mentioned mechanisms may have played a role in
the development of DKA in our case.
DKA is one of the life-threatening serious acute complications of
diabetes. It occurs due to an increase in the counter-regulatory
hormones as a result of insulin insufﬁciency.11 The main factors
that cause DKA include new onset type 1 diabetes, poor compliance
with the insulin regimen, severe stress, trauma, infection, cere-
brovascular accident, surgery, excessive alcohol intake, pancreatitis,
pregnancy, acute myocardial infarction, and drugs that affect thePlease cite this article in press as: Kaya T, et al., Diabetic ketoacidosis as th
features, Turkish Journal of Emergency Medicine (2016), http://dx.doi.orgcarbohydrate metabolism.11 As a novel presentation, in this patient,
we report DKA as the initial manifestatation of pancreatic cys-
tadenocarcinoma. It must be kept in mind that, although rare PDAC
might be the precipitating factor in DKA cases.
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